Gastrointestinal Cancers Symposium

The latest news from ASCO GI, including researcher interviews and physician perspective.


Meeting News CoveragePerspective

Pembrolizumab appears safe, effective in advanced gastric cancer

January 27, 2015
The novel agent pembrolizumab demonstrated promising antitumor activity and manageable toxicity in patients with advanced gastric cancer, according…
Meeting News CoveragePerspective

MM-398 improved outcomes in metastatic pancreatic cancer

January 23, 2015
The addition of the novel agent MM-398 to second-line 5-FU/leucovorin extended survival in patients with metastatic pancreatic cancer, according to…
Meeting News CoveragePerspective

High vitamin D levels linked to improved outcomes in metastatic colorectal cancer

January 13, 2015
High concentrations of vitamin D were associated with improved OS and PFS in patients with metastatic colorectal cancer who received chemotherapy and…
Meeting News CoveragePerspective

Bevacizumab plus FOLFOXIRI extended OS in advanced colorectal cancer

January 13, 2015
Patients with advanced colorectal cancer who underwent first-line treatment with bevacizumab plus FOLFOXIRI chemotherapy demonstrated significantly…
Meeting News CoveragePerspective

Ramucirumab combination benefited patients with advanced colorectal cancer

January 12, 2015
The addition of ramucirumab to standard chemotherapy in a second-line setting extended survival for patients with advanced colorectal cancer…
Meeting News CoveragePerspective

Some patients with rectal cancer may safely avoid surgery

January 12, 2015
A watch-and-wait surveillance strategy conferred similar 4-year survival rates as immediate surgery among patients with stage I to stage III rectal…
Meeting News CoveragePerspective

RAS status determined panitumumab benefit in colorectal cancer

January 21, 2014
Additional RAS testing beyond exon 2 may be necessary to identify patients with metastatic colorectal cancer who are unlikely to benefit from…
Meeting News CoveragePerspective

Oral capecitabine may be new standard of care in rectal cancer

January 16, 2014
Oral capecitabine plus radiation therapy appeared as effective and well tolerated as 5-FU plus radiation therapy and may be considered the new…
Meeting News CoveragePerspective

Chemotherapy combination shows promise as second-line therapy for neuroendocrine tumors

January 15, 2014
The combination of capecitabine plus temozolomide demonstrated efficacy in patients with well- to moderately differentiated neuroendocrine tumors…
Meeting News CoveragePerspective

Vaccine combination extended survival in metastatic pancreatic cancer

January 14, 2014
Combination treatment with the GVAX pancreatic cancer vaccine and CRS-207 vaccine extended survival with manageable toxicity compared with the GVAX…